This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genmab A+s. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Andrew Detzel: Innovator in Antibody Production
Introduction
Andrew Detzel is a notable inventor based in Media, PA (US). He has made significant contributions to the field of biotechnology, particularly in the production of heterodimeric antibodies. His innovative work has the potential to advance therapeutic applications in medicine.
Latest Patents
Andrew Detzel holds a patent for "Methods of producing heterodimeric antibodies." This invention relates to methods that enhance the production of these specialized antibodies, which are crucial for various medical treatments. He has 1 patent to his name, showcasing his expertise in this area.
Career Highlights
Andrew is currently employed at Genmab A/S, a leading biotechnology company focused on developing differentiated antibody therapeutics for the treatment of cancer. His role at Genmab A/S allows him to apply his innovative ideas in a practical setting, contributing to the advancement of medical science.
Collaborations
Throughout his career, Andrew has collaborated with talented individuals such as Pedro Jose Alfonso Martin and Michael Capaldi. These collaborations have fostered a creative environment that encourages the development of groundbreaking solutions in biotechnology.
Conclusion
Andrew Detzel is a prominent figure in the field of antibody production, with a focus on heterodimeric antibodies. His contributions through his patent and work at Genmab A/S highlight his commitment to advancing medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile